Found 5 matching trials
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities PHASE3 Study ASC30-301 (AURORA-1) is a Phase III, global, multicenter, randomized,...
Show More Location
AURORA-1 Clinical Site
Learn More & Join Trial
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes PHASE3 Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized,...
Show More Location
AURORA-2 Clinical Site
Learn More & Join Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities PHASE2 This randomized, double-blind, placebo-controlled phase IIa study is design...
Show More Location
Ascletis Clinical Site
Learn More & Join Trial
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus PHASE2 This randomized, double-blind, placebo-controlled Phase II study is designe...
Show More Status
Active Not Recruiting
Location
Ascletis Clinical Site
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity PHASE1 This is a phase I, randomized, double-blind, placebo-controlled, single and...
Show More Location
Ascletis clinical site
Learn More & Join Trial